Period:
Draw Mode:
| Volume | 91 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | JNJ | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 151.05 | 04:09:07 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 151.05 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 19 | 91 | - | 150.71 - 186.69 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:07:36 | 25 | $ 152.14 | USD |
Johnson and Johnson Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 471.25B | 3.12B | 3.12B | $ 94.94B | $ 17.88B | 6.73 | 22.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 4.45 | 2.99% | 02/17/23 | 226.71k | 0.20% |
Johnson and Johnson News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JNJ Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 153.45 | 154.9499 | 151.03 | 152.87 | 10,317,886 | -2.40 | -1.56% |
| 1 Month | 157.71 | 158.585 | 150.71 | 153.63 | 8,478,236 | -6.66 | -4.22% |
| 3 Months | 177.42 | 180.93 | 150.71 | 161.85 | 8,219,847 | -26.37 | -14.86% |
| 6 Months | 165.74 | 181.039 | 150.71 | 166.62 | 7,436,032 | -14.69 | -8.86% |
| 1 Year | 175.23 | 186.69 | 150.71 | 170.40 | 7,300,161 | -24.18 | -13.8% |
| 3 Years | 117.00 | 186.69 | 109.16 | 161.56 | 7,381,812 | 34.05 | 29.1% |
| 5 Years | 127.63 | 186.69 | 109.16 | 151.02 | 7,306,607 | 23.42 | 18.35% |
Johnson and Johnson Description
| Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total sales are generated in the United States. |